Syngene International Limited (SYNGENE) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹436 (+0.3% day change)
Key ratios
- P/E ratio
- 55.4
- P/B ratio
- 3.24
- ROE (%)
- 6.54
- ROCE (%)
- 9.57
- Debt/Equity
- 0.09
- Dividend yield (%)
- 0.32
- Market cap (₹ Cr)
- 17,549.13
Forensic checks
Piotroski F-Score: 3/9 · Altman Z-Score: 8.51 · Beneish M-Score: -2.59
InvestSights quality score
63.2/100 — Above Average (descriptive data-driven composite; not a recommendation)
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.